Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
7% Marine answer from IR @CaptBeer Investor Relations - As ROI/EU shareholders cant post on SAYTechnologies I ask IR the following questions today (i did also ask at Q4/23 but got no reply)
I asked this morning of IR
Can Amarin Management provide an update on the legal cases ongoing and when they might reach conclusion please?
What legal steps are Amarin taking to defend the 93% market for Cardiovascular Indication against generics who now have a constant 43% market share. The 93% were both referenced by John Thero and Karim Mikhail.
IR responded today
On the open legal matters, are there specific cases that you are referring to? Information on ongoing legal matters can be found in the Company’s 10-K filing beginning on pg. 110 (F-17)
10K_2023.pdf (amarincorp.com)
Can you please let us know what statements you are referring to regarding the 93% market share? Obviously we are at a different time period at this point, so those statements are likely outdated.
I have now asked
The 7% and 93% came from an Amarin statement - DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 25, 2021 (GLOBE NEWSWIRE)
Amarin Expands Cardiovascular Risk Reduction Patent Infringement Lawsuit to Include Health Care Insurance Provider (yahoo.com)
In particular the third paragraph refers to "The Hikma generic icosapent ethyl product has the benefit of court judgments but only with respect to patents related to an indication currently representing no more than 7% of VASCEPA prescriptions in the United States: for use as an adjunct to diet to lower triglyceride levels in adult patients with severely high (=500 mg/dL) triglyceride levels. "
The 7% was regularly used by John Thero when referring to the Marine label and 93% specific for CVD which generics are allegedly infringing on.
If 7% is outdated what is the current legal figure for prescriptions in the United States for use as an adjunct to diet to lower triglyceride levels in adult patients with severely high (=500 mg/dL) triglyceride levels?
They are all returning to the flames today
All the old faces are starting to re-appear - those with a weak constitution should look away. This has normally indicated a pump and dump.
I have asked my legal question of investor relations re saytechnologies.
Good luck all
@CaptBeer Maybe my investorrelations question was timely after all!
Thanks Mike, i appreciate you doing that.
Even if they don't comment (i think you are right that they won't but we can try) they will get the message from the SAY site that defending our legal patents going forward is fundamental and we should never end up in a situation like a few years ago when we the shareholders had to carry the legal fight but without the company's standing.
Help needed please - my shares are in Irish/UK broker so I cant ask a question on the portal - https://app.saytechnologies.com/amarin-2023-q4.
Could someone post a question as follows please:
Can Amarin Management provide an update on the legal cases ongoing and when they might reach conclusion please? Also what legal steps are Amarin taking to defend the 93% Cardiovascular Indication against generics which have a constant 43% market share.
I dont want to get into who has what shares debates, if someone would kindly post my question and let the thumbs up on the say website decide if it is selected or not.
Otherwise UK and Irish shareholders cant ask questions which is as best discrimination. As a group we shouldnt be afraid to have these questions asked if we have no ulterior motivations.
And to make the point I had previously been in touch with Mike E when he was looking for an ROI contact so he knows who I am.
Respectively,
Gus
DMC8 - Why would anyone put themselves through the Amarin experience and not be a genuine shareholder?!
Hi Ziploc_1
I appreciate your reply but want to hear it from the Amarin Board hence the request for someone to post the question on the say portal.
thanks
Gus
Help needed please - my shares are in Irish/UK broker so I cant ask a question on the portal - https://app.saytechnologies.com/amarin-2023-q4.
Could someone post a question as follows please:
Can Amarin Management provide an update on the legal cases ongoing and when they might reach conclusion please? Also what legal steps are Amarin taking to defend the 93% Cardiovascular Indication against generics which have a constant 43% market share.
Thank you.
Game on -
👉Icosapent ethyl for hypertriglyceridaemia and atherosclerosis: greater RESPECT for increased therapeutic use
— Pablo Corral MD (@drpablocorral) October 27, 2023
☝️In summary, we now have evidence from an amalgamation of sources, such as randomized clinical trials, prospective imaging studies, and basic science experiments, that… pic.twitter.com/NWVL9WPQJL
UK and Ireland shareholders cant post questions on the SAY weblink . Could someone ask for me the following please: Amarin previously said that the marine indication was equal to 7% of the market and 93% was generic infringement. What are Amarin doing to legally defend this? TIA.
https://www.sciencedirect.com/science/article/pii/S266666772300051X?via%3Dihub
Tick toc, tick toc, BOOM!
Patent law China -why did we go for marine indication im China and not in Europe? Surely it was to stop generics eating our lunch. Have we now just given generics to enter China. Crazy
Amarin jave jist got regulatory approval to allow generic competition!
BRAVE Results - when are they due? Thanks
This Australia and NZ deal really troubles me.
Well done - screen print $1.72 - will screen print at $10
the morning of the reduce IT results amrn dropped 15% before exploding 324%
Mitigate Results - are they due today?
Emailed HR with the following:
With the current board I have only seen my hard earned savings being destroyed from 6 dollars down to 1.8 dollars. This is after a drop from $24 dollars to $6 under John Thero's leadership.
China seems to be a lost cause with no explanation from the Board.
Germany comes across as being very poorly handled.
Other EU countries are taking too long.
We have no stats for take-up in the UK??
Amarin seems has made a mess of all the legal challenges and didnt support the efforts of retail investors who did make a challenge.
We seem unable as a company to mention Vaskepa/Vazkepa in our tweets, something which has minimal cost.
What is happening with the BRAVE & Mitigate trials?
Why dont you do a comparision between genetic Vascepa and Vascepa for chemical composition?
When will we have a combo pill? Why are you only focusing on Europe with it?
Lizzy241 - 23 would be amazing!
13 dollar
2.40 close today HOD - my guess
Question for Sarissa - what can Sarissa do to stop the current Amarin profiteering from a rise in share price post Sarissa winning?
Can any of the form 4's that have been granted over the years be cancelled?
Looks like i cant vote in Ireland or the UK - Has anyone managed to from these regions?
Thanks Lizzy241, i appreciate you taking the time to do this.
Lizzy241 - can you share a link to the citi reference on the proxy please - havent located it. 50k to Sarissa waiting on it. Thanks
Dublin based - how do i vote?
Is anyone else based in Ireland /UK with shares - did you receive these white /blue cards?
I talked to my UK /Irish stockbroker and they dont vote in proxy votes but can issue me a letter to attend the meeting.
Advice from someone in similar situation welcome.
Pharmacydude - this board only remains useful while Pharmadude and everyone else can civilly express their opinion.
We shouldnt be pushed to support Denner - we should be presented with Facts from both parties going forward and make our own decision on that.
Have a good weekend All
Denner's response - He wrote it like I would have wrote it - as a guy who has lost allot on paper but sees a way to get it back. Denner might have 25m shares verses my 50k, he wants to make his money work. He has my vote
Last Hotel AGM was in the Merion Hotel, Dublin's finest 5 star in 2019 - which i was at.
Raf - i think we need to wait till end of Jan to see if we are losing market share. This weeks numbers for a 4 day week were similar to other 4 day weeks.
Good news for Asians - https://www.sciencedirect.com/science/article/pii/S2666634022005244
Now lets get China approved!!!
Thanks Rafunfafun,
Worth mentioning Vazkepa in Europe.
Is Vazkepa available in Northern Ireland yet? Do you know if a GP can perscribe it? Thanks
Thanks CaptBeer for the clarification. I am so p**sed off with Amarin and the paper losses.
CaptBeer - Great post but this information must come through the Company to any official authority
Closing Germany but getting an acceptable price in Nov 2022 might be part of a BO strategy. What would a European BO with already established sales force want an as yet unproven Amarin German saleforce in any BO??